Iradimed Corp (OQ:IRMD)

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
See Regulatory Filings on SEC
Company Contact
Address: 1025 Willa Springs Dr
Tel: N/A
IR: See website
Key People
Roger Susi
Chairman of the Board, Founder, Chief Technology Officer
Leslie L. McDonnell
President, Chief Executive Officer, Director
Chris Scott
Chief Financial Officer, Corporate Secretary
John K. McCreery
Chief Operating Officer
Brent Johnson
Executive Vice President - Worldwide Sales and Marketing
Francis Casey
Vice President - Quality Assurance and Regulatory Affairs
Steve Nardi
Vice President - Manufacturing
Louis Waldman
Business Overview
IRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, non-ferrous part and other features in order to deliver anesthesia and other IV fluids during various MRI procedures. MRI compatible IV infusion pump system includes the 3860+ MRI compatible IV infusion pump, single-use IV tubing sets, a non-magnetic pole and a lithium battery. In addition, it offers optional upgrade systems, including the 3865 Remote Display/Control, 3861 Side Car, Dose Error Reduction System (DERS) and SpO2 monitor.
Financial Overview
For the six months ended 30 June 2019, Iradimed Corp revenues increased 22% to $17.7M. Net income increased 79% to $3.9M. Revenues reflect United States segment increase of 25% to $14.6M, International segment increase of 9% to $3M. Net income benefited from Other income, net increase from $68K to $171K (income), Research and development decrease of 10% to $632K (expense).
Employees: 95 as of Dec 31, 2018
Reporting Currency: U.S. Dollars
Enterprise value: $220.06M as of Jun 30, 2019
Annual revenue (TTM): $33.62M as of Jun 30, 2019
EBITDA (TTM): $8.22M as of Jun 30, 2019
Net annual income (TTM): $8.04M as of Jun 30, 2019
Free cash flow (TTM): $7.11M as of Jun 30, 2019
Net Debt Last Fiscal Year: N/A
Shares outstanding: 11,369,507 as of Jul 31, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization